In support of a specific role of Sept9 in controlling actomyosin contractility in melanoma, we observed that Sept9 silencing significantly reduced the ability of parental 690.cl2 cells to migrate in transwell assays (Fig. 4 F). This evidence concerns the gene SEPTIN9 and melanoma.